TY - JOUR T1 - Chest CT features of COVID-19 in the region of Abu Dhabi, UAE- A single institute study JF - medRxiv DO - 10.1101/2020.11.14.20229096 SP - 2020.11.14.20229096 AU - Ghufran Aref Saeed AU - Abeer Ahmed Al Helali AU - Safaa Almazrouei AU - Asad Shah AU - Luai A. Ahmed Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/16/2020.11.14.20229096.abstract N2 - OBJECTIVE Our aim is to investigate high resolution CT features of COVID-19 infection in Abu Dhabi, UAE, and to compare the diagnostic performance of CT scan with RT-PCR test.METHODS Data of consecutive patients who were suspected to have COVID-19 infection and presented to our hospital, was collected from March 2, 2020, until April 12, 2020. All patients underwent RT-PCR test; out of which 53.8% had chest CT scan done. Using RT-PCR as a standard reference, the sensitivity and specify of CT scan was calculated. We also analyzed the most common imaging findings in patients with positive RT-PCR results.RESULTS The typical HRCT findings were seen in 50 scans (65.8%) out of total positive ones; 44 (77.2%) with positive RT-PCR results and 6 (31.6%) with negative results. The peripheral disease distribution was seen in 86%, multilobe involvement in 70%, bilateral in 82%, and posterior in 82% of the 50 scans.The ground glass opacities were seen in 50/74 (89.3%) of positive RT-PCR group. The recognized GGO patterns in these scans were: rounded 50%, linear 38%, and crazy-paving 24%.Using RT-PCR as a standard of reference, chest HRCT scan revealed sensitivity of 68.8% and specificity of 70%.CONCLUSION The commonest HRCT findings in patients with COVID-19 pneumonia were peripheral, posterior, bilateral, multilobe rounded ground glass opacities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board (IRB) and Department of health (DOH), Abu Dhabi, United Arab Emirates (UAE) All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data available among request by the Institutional Review Board (IRB) and Department of health (DOH), Abu Dhabi, United Arab Emirates (UAE)COVID-19(coronavirus disease)CRP(C-reactive protein)CT(computed tomography)GGO(ground-glass opacity)HRCT(high-resolution computed tomography)PACS(picture archiving and communication systems)RT-PCR(reverse transcription polymerase chain reaction)CAD(coronary artery disease)SOB(shortness of breath)WHO(World Health Organization) ER -